J N Hagstrom - JoVE Visualize

Showing results (1-10 of 14) with videos related to

Pageof 2

Sort By:

American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|August 15, 2002

Gene therapy for hereditary hematological disordersR W Herzog, J N Hagstrom

Proceedings of the National Academy of Sciences of the United States of America|April 2, 1996

Successful expression of human factor IX following repeat administration of adenoviral vector in miceJ Walter, Q You, J N Hagstrom, et al.

Thrombosis and Haemostasis|December 1, 1995

The pharmacokinetics and lipoprotein fraction distribution of intramuscular vs. oral vitamin K1 supplementation in women of childbearing age: effects on hemostasisJ N Hagstrom, E G Bovill, R F Soll, et al.

The Journal of Pediatrics|December 8, 1998

Prevalence of the factor V leiden mutation in children and neonates with thromboembolic diseaseJ N Hagstrom, J Walter, R Bluebond-Langner, et al.

Blood|February 3, 1998

Human factor IX corrects the bleeding diathesis of mice with hemophilia BS H Kung, J N Hagstrom, D Cass, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 27, 1997

Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virusR W Herzog, J N Hagstrom, S H Kung, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001

Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9P A Fields, V R Arruda, E Armstrong, et al.

Gene Therapy|April 21, 2001

Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 miceP A Fields, E Armstrong, J N Hagstrom, et al.

Blood|February 7, 2001

Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoterJ N Hagstrom, L B Couto, C Scallan, et al.

Journal of the American College of Cardiology|April 1, 1993

Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectorisH K Gold, F W Torres, H D Garabedian, et al.

Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:

Pageof 2

American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|August 15, 2002

Gene therapy for hereditary hematological disordersR W Herzog, J N Hagstrom

Proceedings of the National Academy of Sciences of the United States of America|April 2, 1996

Successful expression of human factor IX following repeat administration of adenoviral vector in miceJ Walter, Q You, J N Hagstrom, et al.

Thrombosis and Haemostasis|December 1, 1995

The pharmacokinetics and lipoprotein fraction distribution of intramuscular vs. oral vitamin K1 supplementation in women of childbearing age: effects on hemostasisJ N Hagstrom, E G Bovill, R F Soll, et al.

The Journal of Pediatrics|December 8, 1998

Prevalence of the factor V leiden mutation in children and neonates with thromboembolic diseaseJ N Hagstrom, J Walter, R Bluebond-Langner, et al.

Blood|February 3, 1998

Human factor IX corrects the bleeding diathesis of mice with hemophilia BS H Kung, J N Hagstrom, D Cass, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 27, 1997

Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virusR W Herzog, J N Hagstrom, S H Kung, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001

Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9P A Fields, V R Arruda, E Armstrong, et al.

Gene Therapy|April 21, 2001

Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 miceP A Fields, E Armstrong, J N Hagstrom, et al.

Blood|February 7, 2001

Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoterJ N Hagstrom, L B Couto, C Scallan, et al.

Journal of the American College of Cardiology|April 1, 1993

Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectorisH K Gold, F W Torres, H D Garabedian, et al.

Pageof 2